Leslie Hirsch
President & CEO | AHA Board of Trustees Member (Term: January 2025–2027) | Saint Peter's Healthcare System
Affiliations
- •President & CEO, Saint Peter's Healthcare System (2017–present; joined as President in 2015). Saint Peter's is a 478-bed acute-care teaching hospital and state-designated children's hospital sponsored by the Roman Catholic Diocese of Metuchen. Major clinical affiliate of Rutgers Biomedical Health and Sciences. Employs 3,600+ staff with 1,000+ physicians; treats 23,000+ inpatients and 245,000+ outpatients annually.
- •AHA Board of Trustees (three-year term beginning January 1, 2025). The Board is the highest policymaking body of the AHA with ultimate authority over governance, direction, and finances.
- •Chair, AHA Regional Policy Board 2 (New Jersey, New York, Pennsylvania) — concurrent with AHA Board term.
- •Chair, NJHA HealthPAC Board of Directors — the political action committee of the New Jersey Hospital Association. This is a current, ongoing role.
- •Fellow, American College of Healthcare Executives (ACHE) — 30+ year fellow.
- •Chairman, Board of Trustees, New Jersey Hospital Association (NJHA) — served two consecutive terms (2015 and 2016). Hirsch was installed as NJHA chairman in January 2015 and retained the chair for a second year after predecessor John A. Brennan departed New Jersey.
- •AHA Regional Policy Board 2 member — served several prior terms before becoming chair.
- •Recipient of Distinguished Service Awards from both ACHE–New Jersey chapter and NJHA.
Financial / Compensation
- •Source: Saint Peter's Healthcare System Inc. Form 990 (EIN 26-2019056), as compiled by GiveFreely/ProPublica Nonprofit Explorer. Filings on record: November 2024, November 2023, November 2022.
- •Saint Peter's Healthcare System Inc. reported revenue of $57,107,559 in FY2023 (note: this entity is the parent management company; the hospital operating entity, Saint Peter's University Hospital, EIN 22-1487330, carries substantially larger revenue and is filed separately).
- •The parent entity lists 225 employees and 12 volunteers.
- •$2M+ total compensation places Hirsch at the upper tier for CEOs of mid-size, single-hospital Catholic systems in the Northeast. For comparison, CEOs of similarly sized New Jersey systems (e.g., Trinitas, Hackettstown) typically report total compensation in the $800K–$1.5M range on their 990s.
- •Hirsch's compensation must be approved by the Saint Peter's board, which is ultimately accountable to the Roman Catholic Diocese of Metuchen as corporate sponsor.
- •Bed Count: 478 licensed beds (acute care)
- •Designations: State-designated children's hospital; regional perinatal center with nationally recognized Level IV NICU
- •Teaching Affiliation: Major clinical affiliate of Rutgers Biomedical Health and Sciences
Lobbying and Political
- •Leslie Hirsch serves as Chair of the NJHA HealthPAC Board of Directors, the political action committee operated by the New Jersey Hospital Association. HealthPAC is the primary vehicle through which New Jersey's hospital industry channels political contributions to state legislators.
- •NJHA is New Jersey's oldest and largest hospital trade association, representing virtually all acute-care hospitals in the state. Its PAC aggregates voluntary contributions from hospital executives and board members across member institutions.
- •As HealthPAC chair, Hirsch directs contribution strategy — deciding which state legislators, candidates, and political committees receive hospital industry money. This role gives him direct personal leverage over New Jersey's health policy agenda at the statehouse level.
- •Specific contribution totals and recipient lists are filed with the New Jersey Election Law Enforcement Commission (ELEC) and can be searched at njelecefilesearch.com. Detailed dollar amounts were not extractable in this research pass but represent a critical data gap for understanding the scope of Hirsch's political influence.
- •Prior HealthPAC chairs include Gary Horan (former CEO of Trinitas Regional Medical Center), indicating this role rotates among senior hospital CEOs in the NJHA orbit.
- •NJHA is registered as a 501(c)(6) trade association (EIN 21-0618622) and engages in extensive lobbying at the state and federal level on behalf of its hospital members.
- •NJHA lobbying priorities align closely with AHA national priorities: opposing Medicaid cuts, defending hospital tax exemptions, fighting site-neutral payment policies, and expanding hospital reimbursement.
- •Hirsch's dual role — NJHA HealthPAC chair and AHA Board trustee — creates a direct conduit between New Jersey state-level political spending and national hospital industry policymaking.
Red Flags
Hirsch served as President & CEO of Saint Clare's Health System in Denville, NJ for approximately seven years (~2008–2015).
Under his tenure, Saint Clare's reported a $14.8 million deficit in FY2010 and a $25.8 million deficit in FY2011 — a rapidly worsening trajectory.
The system was ultimately sold to Prime Healthcare Services, a for-profit California-based hospital chain, through a court-supervised process under New Jersey's Community Health Care Protection Act (CHAPA).
Hirsch himself described the court approval as "a significant milestone in Saint Clare's history" — framing a forced sale of a Catholic nonprofit to a for-profit acquirer as a positive outcome.
Prime Healthcare pledged to invest $30M in capital improvements, maintain charity care levels, and retain employees — but the conversion from nonprofit to for-profit fundamentally altered the institution's mission and tax obligations.
Key question: What was Hirsch's personal compensation at Saint Clare's during the years of deepening losses? If he received substantial pay while the system bled cash and ultimately required rescue acquisition, this is a governance accountability issue. Saint Clare's 990s from this period (filed under Catholic Health Initiatives/CHI) would contain this data.
Hirsch simultaneously holds three interlocking positions: (a) Chair of NJHA HealthPAC (directing state-level political money), (b) Chair of AHA Regional Policy Board 2 (shaping multi-state policy advocacy for NJ/NY/PA), and (c) AHA Board of Trustees member (national hospital industry governance).
This creates a structural conflict of interest: the person deciding which New Jersey legislators receive hospital industry PAC money is also sitting at the table where the national hospital lobby sets its policy agenda and allocates its advocacy resources.
Legislators who receive HealthPAC contributions are the same legislators who vote on hospital reimbursement, tax exemption protections, Certificate of Need laws, and charity care requirements — all issues on which the AHA and NJHA have direct financial stakes.
There is no public evidence that any recusal policy, conflict-of-interest disclosure, or separation of roles exists to address this overlap.
Hirsch's $2M+ total compensation is publicly reported on Form 990, but the corresponding charity care data (actual dollars of free care provided vs. value of tax exemptions received) requires deeper extraction from Schedule H.
If Saint Peter's receives more in tax exemptions than it provides in charity care — a pattern documented at many nonprofit hospitals nationally — then the $2M CEO package is effectively subsidized by taxpayers who receive less community benefit than the exemption costs.
New Jersey does not expressly require nonprofit hospitals to provide community benefits proportional to their tax exemptions, creating a permissive environment for this imbalance.
Saint Peter's is sponsored by the Roman Catholic Diocese of Metuchen, meaning ultimate governance authority rests with the diocese, not an independent community board.
Diocesan-sponsored hospitals often have less transparent governance structures than secular nonprofits. Board composition, executive compensation approval processes, and conflict-of-interest policies may not be publicly disclosed beyond what appears on the 990.
The diocese's role in approving (or failing to scrutinize) a $2M CEO compensation package at a single-hospital system warrants examination.
Saint Peter's status as an independent hospital in an aggressively consolidating New Jersey market makes it both vulnerable to acquisition pressure and valuable as a potential merger target.
Hirsch's extensive political and trade association connections (NJHA chair, HealthPAC chair, AHA trustee) position him as a key power broker in any future consolidation discussions — decisions that would directly affect his own employment, compensation, and institutional legacy.
Any merger or acquisition involving Saint Peter's while Hirsch sits on the AHA Board and chairs the NJHA HealthPAC would create acute conflicts requiring scrutiny.
Pattern Summary
Leslie Hirsch exemplifies a specific archetype within the American hospital industry's power structure: the trade-association insider who accumulates interlocking governance roles across political, state advocacy, and national lobbying tiers — all while drawing seven-figure compensation from a tax-exempt institution. The career arc: Hirsch has led four hospital systems across four states over a 40-year career.